Sign in
OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial
Journal article   Open access  Peer reviewed

OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial

D.S. Moeller, L. Hoffmann, C.M. Lutz, T.B. Nielsen, C. Brink, A.L. Appelt, M.D. Lund, M.S. Nielsen, W. Ottosson, A.A. Khalil, …
Radiotherapy and oncology, Vol.119, pp.S259-S259
01/04/2016
url
https://doi.org/10.1016/S0167-8140(16)31794-7View
Published (Version of record) Open

Metrics

1 Record Views

Details